Literature DB >> 24829416

Targeting antigens through blood dendritic cell antigen 2 on plasmacytoid dendritic cells promotes immunologic tolerance.

Craig P Chappell1, Natalia V Giltiay1, Kevin E Draves1, ChangHung Chen2, Martha S Hayden-Ledbetter1, Mark J Shlomchik3, Daniel H Kaplan4, Edward A Clark1,5.   

Abstract

The C-type lectin receptor blood dendritic cell Ag 2 (BDCA2) is expressed exclusively on human plasmacytoid DCs (pDCs) and plays a role in Ag capture, internalization, and presentation to T cells. We used transgenic mice that express human BDCA2 and anti-BDCA2 mAbs to deliver Ags directly to BDCA2 on pDCs in vivo. Targeting Ag to pDCs in this manner resulted in significant suppression of Ag-specific CD4(+) T cell and Ab responses upon secondary exposure to Ag in the presence of adjuvant. Suppression of Ab responses required both a decrease in effector CD4(+) T cells and preservation of Foxp3(+) regulatory T cells (Tregs). Reduction in Treg numbers following Ag delivery to BDCA2 restored both CD4(+) T cell activation and Ab responses, demonstrating that Tregs were required for the observed tolerance. Our results demonstrate that Ag delivery to pDCs through BDCA2 is an effective method to induce immunological tolerance, which may be useful for treating autoimmune diseases or to inhibit unwanted Ab responses.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24829416      PMCID: PMC4048786          DOI: 10.4049/jimmunol.1303259

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  65 in total

Review 1.  Antigen-presentation properties of plasmacytoid dendritic cells.

Authors:  José A Villadangos; Louise Young
Journal:  Immunity       Date:  2008-09-19       Impact factor: 31.745

2.  Functional dichotomy of plasmacytoid dendritic cells: antigen-specific activation of T cells versus production of type I interferon.

Authors:  Peter S Jaehn; Kurt S Zaenker; Juergen Schmitz; Andrzej Dzionek
Journal:  Eur J Immunol       Date:  2008-07       Impact factor: 5.532

3.  Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I.

Authors:  Tiziana Di Pucchio; Bithi Chatterjee; Anna Smed-Sörensen; Sandra Clayton; Adam Palazzo; Monica Montes; Yaming Xue; Ira Mellman; Jacques Banchereau; John E Connolly
Journal:  Nat Immunol       Date:  2008-03-30       Impact factor: 25.606

4.  De novo production of antigen-specific suppressor cells in vivo.

Authors:  Karsten Kretschmer; Tracy S P Heng; Harald von Boehmer
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

5.  CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells.

Authors:  Sayuri Yamazaki; Diana Dudziak; Gordon F Heidkamp; Christopher Fiorese; Anthony J Bonito; Kayo Inaba; Michel C Nussenzweig; Ralph M Steinman
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

6.  The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation.

Authors:  Wei Chen; Xueqing Liang; Amanda J Peterson; David H Munn; Bruce R Blazar
Journal:  J Immunol       Date:  2008-10-15       Impact factor: 5.422

7.  CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease.

Authors:  Husein Hadeiba; Tohru Sato; Aida Habtezion; Cecilia Oderup; Junliang Pan; Eugene C Butcher
Journal:  Nat Immunol       Date:  2008-10-05       Impact factor: 25.606

8.  Plasmacytoid dendritic cells regulate breach of self-tolerance in autoimmune arthritis.

Authors:  Sarah L Jongbloed; Robert A Benson; Mohammed B Nickdel; Paul Garside; Iain B McInnes; James M Brewer
Journal:  J Immunol       Date:  2009-01-15       Impact factor: 5.422

9.  Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-alpha production.

Authors:  Friederike Meyer-Wentrup; Daniel Benitez-Ribas; Paul J Tacken; Cornelis J A Punt; Carl G Figdor; I Jolanda M de Vries; Gosse J Adema
Journal:  Blood       Date:  2008-02-07       Impact factor: 22.113

10.  BDCA2/Fc epsilon RI gamma complex signals through a novel BCR-like pathway in human plasmacytoid dendritic cells.

Authors:  Wei Cao; Li Zhang; David B Rosen; Laura Bover; Gokuran Watanabe; Musheng Bao; Lewis L Lanier; Yong-Jun Liu
Journal:  PLoS Biol       Date:  2007-09-11       Impact factor: 8.029

View more
  12 in total

Review 1.  FOXP3-Positive Regulatory T Cells and Kidney Allograft Tolerance.

Authors:  Alessandro Alessandrini; Laurence A Turka
Journal:  Am J Kidney Dis       Date:  2016-12-31       Impact factor: 8.860

2.  Targeting Antigens to CD180 but Not CD40 Programs Immature and Mature B Cell Subsets to Become Efficient APCs.

Authors:  Kelsey Roe; Geraldine L Shu; Kevin E Draves; Daniela Giordano; Marion Pepper; Edward A Clark
Journal:  J Immunol       Date:  2019-09-04       Impact factor: 5.422

Review 3.  Dendritic Cells As Inducers of Peripheral Tolerance.

Authors:  Courtney A Iberg; Andrew Jones; Daniel Hawiger
Journal:  Trends Immunol       Date:  2017-08-18       Impact factor: 16.687

Review 4.  Cellular and molecular targeting for nanotherapeutics in transplantation tolerance.

Authors:  Kelan A Hlavaty; Xunrong Luo; Lonnie D Shea; Stephen D Miller
Journal:  Clin Immunol       Date:  2015-03-21       Impact factor: 3.969

Review 5.  The multifaceted biology of plasmacytoid dendritic cells.

Authors:  Melissa Swiecki; Marco Colonna
Journal:  Nat Rev Immunol       Date:  2015-07-10       Impact factor: 53.106

Review 6.  Human dendritic cell subsets and function in health and disease.

Authors:  Meredith O'Keeffe; Wai Hong Mok; Kristen J Radford
Journal:  Cell Mol Life Sci       Date:  2015-08-05       Impact factor: 9.261

Review 7.  Targeting C-Type Lectin Receptors for Cancer Immunity.

Authors:  Huimin Yan; Tomomori Kamiya; Papawee Suabjakyong; Noriko M Tsuji
Journal:  Front Immunol       Date:  2015-08-24       Impact factor: 7.561

8.  Reduced Dendritic Cells Expressing CD200R1 in Children with Inflammatory Bowel Disease: Correlation with Th17 and Regulatory T Cells.

Authors:  Mohamed F Elshal; Alia M Aldahlawi; Omar I Saadah; J Philip McCoy
Journal:  Int J Mol Sci       Date:  2015-12-04       Impact factor: 5.923

Review 9.  Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies.

Authors:  Christian H K Lehmann; Lukas Heger; Gordon F Heidkamp; Anna Baranska; Jennifer J Lühr; Alana Hoffmann; Diana Dudziak
Journal:  Vaccines (Basel)       Date:  2016-03-28

Review 10.  Role of Dendritic Cells in the Induction of Lymphocyte Tolerance.

Authors:  Fabiola Osorio; Camila Fuentes; Mercedes N López; Flavio Salazar-Onfray; Fermín E González
Journal:  Front Immunol       Date:  2015-10-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.